Poly(lactic-co-glycolic acid)/Polycaprolactone Nanofibrous Membranes for High-Efficient Capture of Nano- and Microsized Particulate Matter
The incidence of many diseases is closely related to air pollution. Suspended particulate matter of different sizes represents a major source of environmental pollution. Fine particles, especially ultrafine particles smaller than 2.5 μm, might be more harmful to human health because of their extremely small size, which enables them to penetrate human lungs and bronchi and makes them difficult to filter out. Therefore, the fatal risks associated with PM call for the development of air purification materials with high efficiency and low resistance. In this study, poly(lactic-co-glycolic acid) and polycaprolactone were used to prepare nanofibrous membranes suitable for the efficient capture of particulate matter formed in haze-fog episodes, especially particles smaller than 0.5 μm. The present nanofibrous membranes exhibit superior filtration efficiency for particulate matter, with a much lower pressure drop compared to typical commercial microfiber air filters. Thanks to the combination of small pore size, high porosity, and robust mechanical properties, the poly(lactic-co-glycolic acid)/polycaprolactone (6:4) composite membrane exhibits a high filtration efficiency of 97.81% and a low pressure drop of 181 Pa. These favorable features, combined with the easy availability and biocompatibility of the component materials, highlight the promising potential of the present nanofibrous membranes for the development of personal wearable air purifiers.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: January 1, 2018
More about this publication?
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites